Baird Medical (BDMD) continues global expansion

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) recently announced a significant milestone in its international expansion. The U.S. Food and Drug Administration (FDA) has issued a Certificate to Foreign Government (CFG) to the Egyptian regulatory authorities, affirming the company's compliance with U.S. medical device standards and facilitating its market entry into Egypt. Simultaneously, Baird Medical has formally submitted regulatory registration applications in Egypt, Hong Kong, Thailand, Malaysia, Kazakhstan, Sri Lanka, and India. The Company anticipates timely approvals in these key markets, further accelerating its global footprint. This follows the successful regulatory approval in Indonesia in March 2025, marking another strategic step in Baird Medical's international growth.

In preparation for market entry, Baird Medical has initiated partnerships with leading healthcare institutions across these regions to establish robust distribution networks and conduct comprehensive training programs on microwave ablation (MWA) procedures. These initiatives are strategically implemented to ensure the seamless introduction of the Company's advanced medical solutions, enabling immediate patient access upon receipt of regulatory approvals.

Microwave ablation is a minimally invasive procedure widely used in the treatment of thyroid nodules and tumors. Leveraging targeted microwave energy to ablate abnormal tissues, the technology offers exceptional precision, high ablation efficiency, and effective hemostasis. It minimizes damage to healthy tissues and blood vessels, with virtually no side effects. As a forward-thinking medical device company specializing in the development of AI-powered surgical robotic systems and innovative surgical instruments, Baird Medical is committed to delivering precise, safe, and efficient minimally invasive treatments to patients worldwide through its cutting-edge MWA technology.

You May Also Be Interested In

• Curaleaf pushes back on Aurora's rejection of takeover bid
• Five Below (FIVE) call put ratio 1 call to 1.3 puts into quarter results
• Broadcom (AVGO) call put ratio 1.6 calls to 1 put into quarter results